Acetylcholine is released in the basolateral amygdala in response to predictors of reward and enhances learning of cue-reward contingency

  1. Richard B Crouse
  2. Kristen Kim
  3. Hannah M Batchelor
  4. Eric M Girardi
  5. Rufina Kamaletdinova
  6. Justin Chan
  7. Prithviraj Rajebhosale
  8. Steven T Pittenger
  9. Lorna W Role
  10. David A Talmage
  11. Miao Jing
  12. Yulong Li
  13. Xiao-Bing Gao
  14. Yann S Mineur
  15. Marina R Picciotto  Is a corresponding author
  1. Yale University, United States
  2. NIH, United States
  3. Chinese Institute for Brain Research, China
  4. Peiking University, China
  5. Yale University School of Medicine, United States

Abstract

The basolateral amygdala (BLA) is critical for associating initially neutral cues with appetitive and aversive stimuli and receives dense neuromodulatory acetylcholine (ACh) projections. We measured BLA ACh signaling and activity of neurons expressing CaMKIIα (a marker for glutamatergic principal cells) in mice during cue-reward learning using a fluorescent ACh sensor and calcium indicators. We found that ACh levels and nucleus basalis of Meynert (NBM) cholinergic terminal activity in the BLA (NBM-BLA) increased sharply in response to reward-related events and shifted as mice learned the cue-reward contingency. BLA CaMKIIα neuron activity followed reward retrieval and moved to the reward-predictive cue after task acquisition. Optical stimulation of cholinergic NBM-BLA terminal fibers led to quicker acquisition of the cue-reward contingency. These results indicate BLA ACh signaling carries important information about salient events in cue-reward learning and provides a framework for understanding how ACh signaling contributes to shaping BLA responses to emotional stimuli.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for all experiments on Dryad Digital Repository: doi:10.5061/dryad.3xsj3txcf

The following data sets were generated

Article and author information

Author details

  1. Richard B Crouse

    Interdepartmental Neuroscience Program, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9509-9263
  2. Kristen Kim

    Interdepartmental Neuroscience Program, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Hannah M Batchelor

    Interdepartmental Neuroscience Program, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Eric M Girardi

    Psychiatry, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Rufina Kamaletdinova

    Psychiatry, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3650-8207
  6. Justin Chan

    Psychiatry, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Prithviraj Rajebhosale

    NINDS, NIH, Bethesda, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9893-3025
  8. Steven T Pittenger

    Psychiatry, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Lorna W Role

    NINDS, NIH, Bethesda, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5851-212X
  10. David A Talmage

    NIMH, NIH, Bethesda, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Miao Jing

    Chinese Institute for Brain Research, Chinese Institute for Brain Research, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  12. Yulong Li

    School of Life Sciences, Peiking University, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  13. Xiao-Bing Gao

    Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale University School of Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Yann S Mineur

    Psychiatry, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Marina R Picciotto

    Psychiatry, Yale University, New Haven, United States
    For correspondence
    marina.picciotto@yale.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4404-1280

Funding

National Institute on Drug Abuse (DA14241)

  • Richard B Crouse
  • Kristen Kim
  • Hannah M Batchelor
  • Rufina Kamaletdinova
  • Justin Chan
  • Steven T Pittenger
  • Yann S Mineur
  • Marina R Picciotto

National Institute on Drug Abuse (DA037566)

  • Richard B Crouse
  • Kristen Kim
  • Hannah M Batchelor
  • Rufina Kamaletdinova
  • Justin Chan
  • Steven T Pittenger
  • Yann S Mineur
  • Marina R Picciotto

National Institute of Mental Health (MH077681)

  • Richard B Crouse
  • Kristen Kim
  • Hannah M Batchelor
  • Rufina Kamaletdinova
  • Justin Chan
  • Steven T Pittenger
  • Yann S Mineur
  • Marina R Picciotto

National Institute of Neurological Disorders and Stroke (NS022061)

  • Prithviraj Rajebhosale
  • Lorna W Role
  • David A Talmage

National Institute of Mental Health (MH109104)

  • Prithviraj Rajebhosale
  • Lorna W Role
  • David A Talmage

National Institute on Drug Abuse (DA046160)

  • Xiao-Bing Gao

National Institute of Neurological Disorders and Stroke (Intramural)

  • Prithviraj Rajebhosale
  • Lorna W Role

National Institute of Mental Health (Intramural)

  • Prithviraj Rajebhosale
  • David A Talmage

National Institute of Neurological Disorders and Stroke (T32-NS007224)

  • Richard B Crouse

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All procedures were approved by the Yale University Institutional Animal Care & Use Committee in compliance with the National Institute of Health's Guide for the Care and Use of Laboratory Animals. (protocol: 2019-07895)

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 7,108
    views
  • 853
    downloads
  • 73
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Richard B Crouse
  2. Kristen Kim
  3. Hannah M Batchelor
  4. Eric M Girardi
  5. Rufina Kamaletdinova
  6. Justin Chan
  7. Prithviraj Rajebhosale
  8. Steven T Pittenger
  9. Lorna W Role
  10. David A Talmage
  11. Miao Jing
  12. Yulong Li
  13. Xiao-Bing Gao
  14. Yann S Mineur
  15. Marina R Picciotto
(2020)
Acetylcholine is released in the basolateral amygdala in response to predictors of reward and enhances learning of cue-reward contingency
eLife 9:e57335.
https://doi.org/10.7554/eLife.57335

Share this article

https://doi.org/10.7554/eLife.57335

Further reading

    1. Cell Biology
    2. Neuroscience
    Jun Sun, Francisca Rojo-Cortes ... Alicia Hidalgo
    Research Article

    Experience shapes the brain as neural circuits can be modified by neural stimulation or the lack of it. The molecular mechanisms underlying structural circuit plasticity and how plasticity modifies behaviour are poorly understood. Subjective experience requires dopamine, a neuromodulator that assigns a value to stimuli, and it also controls behaviour, including locomotion, learning, and memory. In Drosophila, Toll receptors are ideally placed to translate experience into structural brain change. Toll-6 is expressed in dopaminergic neurons (DANs), raising the intriguing possibility that Toll-6 could regulate structural plasticity in dopaminergic circuits. Drosophila neurotrophin-2 (DNT-2) is the ligand for Toll-6 and Kek-6, but whether it is required for circuit structural plasticity was unknown. Here, we show that DNT-2-expressing neurons connect with DANs, and they modulate each other. Loss of function for DNT-2 or its receptors Toll-6 and kinase-less Trk-like kek-6 caused DAN and synapse loss, impaired dendrite growth and connectivity, decreased synaptic sites, and caused locomotion deficits. In contrast, over-expressed DNT-2 increased DAN cell number, dendrite complexity, and promoted synaptogenesis. Neuronal activity modified DNT-2, increased synaptogenesis in DNT-2-positive neurons and DANs, and over-expression of DNT-2 did too. Altering the levels of DNT-2 or Toll-6 also modified dopamine-dependent behaviours, including locomotion and long-term memory. To conclude, a feedback loop involving dopamine and DNT-2 highlighted the circuits engaged, and DNT-2 with Toll-6 and Kek-6 induced structural plasticity in this circuit modifying brain function and behaviour.

    1. Neuroscience
    Mengqiao Cui, Xiaoyuan Pan ... Jun-Li Cao
    Research Article

    Memory impairment in chronic pain patients is substantial and common, and few therapeutic strategies are available. Chronic pain-related memory impairment has susceptible and unsusceptible features. Therefore, exploring the underlying mechanisms of its vulnerability is essential for developing effective treatments. Here, combining two spatial memory tests (Y-maze test and Morris water maze), we segregated chronic pain mice into memory impairment-susceptible and -unsusceptible subpopulations in a chronic neuropathic pain model induced by chronic constrictive injury of the sciatic nerve. RNA-Seq analysis and gain/loss-of-function study revealed that S1P/S1PR1 signaling is a determinant for vulnerability to chronic pain-related memory impairment. Knockdown of the S1PR1 in the dentate gyrus (DG) promoted a susceptible phenotype and led to structural plasticity changes of reduced excitatory synapse formation and abnormal spine morphology as observed in susceptible mice, while overexpression of the S1PR1 and pharmacological administration of S1PR1 agonist in the DG promoted an unsusceptible phenotype and prevented the occurrence of memory impairment, and rescued the morphological abnormality. Finally, the Gene Ontology (GO) enrichment analysis and biochemical evidence indicated that downregulation of S1PR1 in susceptible mice may impair DG structural plasticity via interaction with actin cytoskeleton rearrangement-related signaling pathways including Itga2 and its downstream Rac1/Cdc42 signaling and Arp2/3 cascade. These results reveal a novel mechanism and provide a promising preventive and therapeutic molecular target for vulnerability to chronic pain-related memory impairment.